ABVC BioPharma, Inc. (ABVC)
0.8444
-0.08
(-8.22%)
USD |
NASDAQ |
Aug 24, 16:00
0.8444
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -125.2% |
| June 30, 2024 | -894.4% |
| March 31, 2024 | -244.0K% |
| December 31, 2023 | -151.4K% |
| September 30, 2023 | -21.18K% |
| June 30, 2023 | -37.95K% |
| March 31, 2023 | -1.48K% |
| December 31, 2022 | -764.2% |
| September 30, 2022 | -8.93K% |
| June 30, 2022 | -622.3% |
| March 31, 2022 | -23.69K% |
| September 30, 2021 | -1.91K% |
| June 30, 2021 | -6.54K% |
| March 31, 2021 | -454.1% |
| December 31, 2020 | -7.99K% |
| September 30, 2020 | -1.84K% |
| June 30, 2020 | -964.3% |
| March 31, 2020 | -1.66K% |
| December 31, 2019 | -1.12K% |
| September 30, 2019 | -672.6% |
| June 30, 2019 | -320.4% |
| March 31, 2019 | -411.5% |
| December 31, 2018 | -130.9K% |
| September 30, 2018 | -98.19K% |
| June 30, 2018 | -23.00K% |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | -2.81K% |
| June 30, 2015 | |
| March 31, 2015 | 47.83% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | -13.04K% |
| December 31, 2012 | -2.20K% |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | -9.26K% |
| December 31, 2011 | -13.86K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 10.15% |
| Perspective Therapeutics, Inc. | -33.31K% |
| MiMedx Group, Inc. | -23.06% |
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -13.17% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.92% |
| Return on Assets | -38.92% |
| Return on Invested Capital | -49.66% |
| Return on Net Operating Assets | -55.09% |